Mortality in Pregnant Women with COVID-19 in Mexico
DOI:
https://doi.org/10.9734/bpi/nramms/v5/1365GKeywords:
COVID-19, fatality, pregnancy, reproductive age, SARS-CoV-2, surveillance systemAbstract
During the pandemic by SARS-CoV-2 the pregnant women, people older than 60 years, lung problems (asthma, COPD), heart disease, brain and nervous system conditions, cancer and certain blood disorders, weakened immune system, chronic kidney, liver disease, mental health condition, down syndrome and kids under 5 years are considered a group of risk, although pregnant women infected with SARS-COV-2 are predominantly asymptomatic or present mild COVID-19 very similar to non-pregnant women. The aim is review the mortality by COVID-19 in pregnant women in Mexico.
Sever acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virus that are more similar to bats coronavirus than human SARS. COVID-19 starts as a pneumonia case with unfamiliar etiology and origin, The coronavirus disease 19 is a highly transmittable and pathogenic viral infection caused by severe acute respiratory syndrome coronavirus 2. Genomic analysis revealed that SARS-CoV-2 is phylogenetically related to severe acute respiratory syndrome-like (SARS-like) bat viruses, therefore bats could be the possible primary reservoir. Main symptoms reported in COVID 19: fever, dry cough, asthenia, myalgia, arthralgias, headache chills, odynophagia and dyspnea. Anosmia, ageusia, diarrhea, vomiting, nasal congestion and hemoptysis are less common.
According to different studies made in Mexico, there is no evidence that pregnant women are more susceptible to severe SARS-CoV-2 infection. However, they being considered as a population group at risk, it has been shown that comparing other comorbidities such as pneumonia, asthma, COPD and even the increase in age, they are susceptible to the increase mortality rate and complications in patients affected by COVID 19.